1. Home
  2. RGP vs OKYO Comparison

RGP vs OKYO Comparison

Compare RGP & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

N/A

Current Price

$2.71

Market Cap

94.7M

ML Signal

N/A

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

N/A

Current Price

$1.43

Market Cap

78.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RGP
OKYO
Founded
1996
2007
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.7M
78.2M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
RGP
OKYO
Price
$2.71
$1.43
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$6.50
★ $8.33
AVG Volume (30 Days)
★ 473.9K
43.7K
Earning Date
10-07-2026
07-20-2026
Dividend Yield
★ 9.86%
N/A
EPS Growth
★ 79.14
N/A
EPS
N/A
★ N/A
Revenue
★ $452,006,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.19
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.33
$1.26
52 Week High
$5.37
$3.20

Technical Indicators

Market Signals
Indicator
RGP
OKYO
Relative Strength Index (RSI) 37.22 49.10
Support Level $2.33 $1.31
Resistance Level $3.86 $1.71
Average True Range (ATR) 0.13 0.08
MACD 0.05 0.01
Stochastic Oscillator 73.15 21.44

Price Performance

Historical Comparison
RGP
OKYO

About RGP Resources Connection Inc.

Resources Connection Inc is a professional services firm. Its segments include On-Demand Talent provides businesses with a go-to source for bringing in experts when its needed, serving the office of the CFO; Consulting drives transformation across people, processes and technology across domain areas including finance, technology and digital, risk and compliance and operational performance; Europe & Asia Pacific offers both on-demand and consulting services to clients throughout Europe and Asia Pacific; Outsourced Services; and Sitrick. It derives the majority of revenue from On-Demand Talent segment. Geographically, it operates in United States and internationally.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

Share on Social Networks: